Biography Ron Cami is an Executive Partner at Flagship Pioneering, a leading life sciences venture firm best known for founding and building Moderna. At Flagship, Ron is a member of the Executive Leadership Team and leads strategic initiatives and capital transactions. Previously, he was a Partner of the U.S. healthcare asset management platform of the B-FLEXION group (formerly Waypoint Group), where he served on the group’s Board of Directors and Executive Committee and oversaw its U.S. investment partnerships and direct holdings. Before joining B-FLEXION, Ron was a Partner and General Counsel of TPG Global in San Francisco and a member of its Investment Review Committee. Earlier in his career, he was a Partner at Cravath, Swaine & Moore and at Davis Polk & Wardwell. Currently, Ron serves on the board of Sail Biosciences and Ampersand Biosciences. Ron received his bachelor’s degree from Harvard and a law degree from Rutgers. He served as law clerk to the Honorable Kevin Thomas Duffy in the Southern District of New York.